OPAT
Showing 1 - 25 of 38
Bronchiectasis, Cystic Fibrosis, Pseudomonas Aeruginosa Trial (Ceftolozane/tazobactam)
Not yet recruiting
- Bronchiectasis
- +3 more
- (no location specified)
Sep 6, 2023
Gather Clinical Information From Patients Following Hospital
Recruiting
- Outpatient Parenteral Antibiotic Therapy
- OPAT
- Focus Group
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Jul 6, 2022
Opioid Use Disorder Trial in Saint Louis (OPAT for PWID)
Recruiting
- Opioid Use Disorder
- OPAT for PWID
-
Saint Louis, MissouriWashington Univeristy
Mar 18, 2022
Implementation of OPAT in Germany Trial in Cologne (Outpatient Parenteral Antibiotic Therapy)
Recruiting
- Implementation of OPAT in Germany
- Outpatient Parenteral Antibiotic Therapy
-
Cologne, GermanyUniversity of Cologne
Oct 5, 2021
Outpatient Parenteral Antimicrobial Therapy (OPAT)
Recruiting
- Infections
- Outpatient parenteral antimicrobial therapy
-
Lausanne, SwitzerlandDepartment of Outpatient Care and Community Medicine, University
Oct 22, 2020
Implementation of OPAT in Germany Trial in Cologne (Outpatient Parenteral Antibiotic Therapy)
Recruiting
- Implementation of OPAT in Germany
- Outpatient Parenteral Antibiotic Therapy
-
Cologne, GermanyUniversity Hospital of Cologne
Nov 3, 2020
Outpatient Trial in Monterrey (Place of treatment)
Recruiting
- Outpatient
- Place of treatment
-
Monterrey, Nuevo Leon, MexicoHospital Universitario José E. Gonzalez
Jan 28, 2023
Endocarditis Infective Trial in Barcelona (Cefaclor, Ciprofloxacin Tablets, Ciprofloxacin Injection)
Not yet recruiting
- Endocarditis Infective
- Cefaclor
- +23 more
-
Barcelona, SpainHospital Clinic i Provincial de Barcelona
May 26, 2022
Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection Trial in Morgantown (Amoxicillin,
Not yet recruiting
- Endovascular Infection
- +5 more
- Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid
- Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem
-
Morgantown, West VirginiaWest Virginia University
Jul 24, 2023
Drug Use, Opioid-use Disorder Trial in Lexington (Buprenorphine and Outpatient Parenteral Antibiotic Therapy, Buprenorphine and
Recruiting
- Drug Use
- Opioid-use Disorder
- Buprenorphine and Outpatient Parenteral Antibiotic Therapy
- Buprenorphine and standard of care antibiotic treatment
-
Lexington, KentuckyUniversity of Kentucky
Nov 7, 2022
Infection Trial in Winston-Salem (Vancomycin CI, Vancomycin II)
Recruiting
- Infection
- Vancomycin CI
- Vancomycin II
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Feb 16, 2022
Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)
Not yet recruiting
- Diffuse Large B-cell Lymphoma (DLBCL)
-
Lanzhou, Gansu, ChinaThe First Hospital of Lanzhou University
Oct 23, 2022
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Sepsis Bacterial Trial (PET/CT)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- +6 more
- PET/CT
- (no location specified)
Apr 29, 2022
Infection, Bacterial Trial (Isothermal pouch)
Not yet recruiting
- Infection, Bacterial
- Isothermal pouch
- (no location specified)
Aug 22, 2022
Vascular Surgery Admissions inTertiary Care Hospital in
Not yet recruiting
- Vascular Diseases
- Surgery
- (no location specified)
Jun 21, 2022
Endocarditis, Bacterial, Opioid-use Disorder, Buprenorphine Trial in Lexington (Outpatient parenteral antibiotic therapy)
Completed
- Endocarditis, Bacterial
- +3 more
- Outpatient parenteral antibiotic therapy
-
Lexington, KentuckyUniversity of Kentucky
Jan 21, 2019
Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)
Recruiting
- Waldenstrom Macroglobulinemia
- Zanubrutinib, Bendamustine and Rituximab
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jun 13, 2023
Staphylococcus Aureus Bacteremia Trial in Worldwide (Cefazolin, Penicillin, Clindamycin)
Recruiting
- Staphylococcus Aureus Bacteremia
- Cefazolin
- +4 more
-
Garran, Australia Capital Territory, Australia
- +73 more
Feb 23, 2022
Thrombotic Thrombocytopenic Purpura, Acquired Trial in Beijing (Bortezomib Injection)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura, Acquired
- Bortezomib Injection
-
Beijing, (Select), ChinaPeking Union Medical College Hospital
Nov 22, 2021
Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic
Recruiting
- Atrial Fibrillation
- +4 more
- Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
-
New Hyde Park, New YorkNorthwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022
Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA
Not yet recruiting
- Adrenal Cortical Carcinoma
- +3 more
- individualized mRNA neoantigen vaccine (mRNA-0523-L001)
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023
Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) Trial in Basel (FLU or CZO as continuous infusion, standard FLU
Not yet recruiting
- Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)
- FLU or CZO as continuous infusion
- standard FLU or CZO intermittent bolus administration
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Internal Medicine
Dec 14, 2022
Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia Trial in Beijing (combination of a
Recruiting
- Autoimmune Hemolytic Anemia
- Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
- combination of a single dose anti-CD20 antibody and bortezomib
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 12, 2021
Beta-lactam Pharmacokinetics in Secondary Care
Completed
- Pharmacokinetics
- +2 more
- Beta-lactam antibiotic
-
London, United KingdomHammersmith Hospital
Aug 4, 2021
Gram-Positive Bacterial Infections, Gram-Positive Bacteraemia, Substance Use Disorders Trial in Aurora (Dalbavancin)
Enrolling by invitation
- Gram-Positive Bacterial Infections
- +3 more
-
Aurora, ColoradoUniversity of Colorado Hospital
May 4, 2021